Arrowhead Pharmaceuticals (ARWR) Q1 2025 Earnings

10FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-1.39
-1.08
-0.78
-0.47

Details

Expected EPS
-0.475863
Actual EPS
-1.39
Surprise EPS
-0.91
Surprise Percent
+192.1%

Description

Arrowhead Pharmaceuticals (ARWR) has reported earnings of -1.39 per share for Q1 2025.

0 Comments

Share your thoughts